Distinct risks of exacerbation and lung function decline between never-smokers and ever-smokers with COPD

被引:0
|
作者
Park, Heemoon [1 ]
Jo, Soo Min [2 ]
Jin, Kwang Nam [3 ]
Lee, Hyo Jin [1 ]
Lee, Hyun Woo [1 ]
Park, Tae Yun [1 ]
Heo, Eun Young [1 ]
Kim, Deog Kyeom [1 ]
Lee, Jung-Kyu [1 ]
机构
[1] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med,Seoul Metropolitan Govt, 20 Boramaero,5 Gil, Seoul 07061, South Korea
[2] Dongguk Univ, Ilsan Hosp, Dept Internal Med, Div Pulm & Crit Care Med,Seoul Metropolitan Govt, Goyang, South Korea
[3] Seoul Natl Univ, Boramae Med Ctr, Dept Radiol, Seoul Metropolitan Govt, Seoul, South Korea
来源
BMC PULMONARY MEDICINE | 2025年 / 25卷 / 01期
关键词
COPD; Never-smoker; Exacerbation; Lung function; OBSTRUCTIVE PULMONARY-DISEASE; POPULATION;
D O I
10.1186/s12890-025-03604-1
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundChronic obstructive pulmonary disease (COPD) can occur in patients without a history of smoking, which is a strong risk factor for COPD. However, few studies have focused on the prognosis of never-smokers with COPD. We investigated the difference of the longitudinal clinical outcomes between never-smokers and ever-smokers with COPD.MethodsWe retrospectively analyzed patients with COPD who underwent chest computed tomography and longitudinal lung function tests from January 2013 to December 2020. We classified patients according to smoking status and examined their histories of acute exacerbation and long-term changes in lung function.ResultsAmong 583 patients with COPD, 75 (12.9%) had no smoking history. These never-smokers with COPD were predominantly women; they had a lower forced vital capacity and a higher prevalence of asthma, history of tuberculosis, tuberculosis-destroyed lung, and bronchiectasis, but a lower prevalence of emphysema, relative to ever-smokers with COPD. Never-smokers with COPD had significantly lower risks of subsequent moderate to severe exacerbation (beta +/- standard error, - 0.4 +/- 0.12; P = 0.001), any exacerbation (adjusted odds ratio, 0.46; 95% confidence interval, 0.26 - 0.8; P = 0.006), and frequent exacerbation (adjusted odds ratio, 0.28; 95% confidence interval, 0.09 - 0.89; P = 0.03) than ever-smokers with COPD. Never-smokers with COPD also showed significantly slower annual decline of forced expiratory volume in 1 s than ever-smokers with COPD (- 15.7 +/- 4.7 vs. -30.4 +/- 2.9 mL, respectively; P = 0.03).ConclusionsNever-smokers with COPD had significantly fewer acute exacerbations and slower decline of lung function than ever-smokers with COPD during longitudinal follow-up.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Lung cancer in never-smokers - what are the differences?
    Dias, Margarida
    Linhas, Rita
    Campainha, Sergio
    Conde, Sara
    Barroso, Ana
    ACTA ONCOLOGICA, 2017, 56 (07) : 931 - 935
  • [32] The impact of depression and anxiety on never-smokers COPD patients
    Torres, Rebeca Sicilia
    Cabrera, C.
    Casanova, C.
    Leon, F.
    Julia, G.
    Marin, J.
    De Torres, P.
    Garcia, M. A.
    Divo, M.
    Celli, B.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [33] Small cell lung cancer in never-smokers
    Torres-Duran, Maria
    Ruano-Ravina, Alberto
    Kelsey, Karl T.
    Parente-Lamelas, Isaura
    Provencio, Mariano
    Leiro-Fernandez, Virginia
    Abal-Arca, Jose
    Montero-Martinez, Carmen
    Vidal-Garcia, Iria
    Pena, Carolina
    Castro-Anon, Olalla
    Golpe-Gomez, Antonio
    Martinez, Cristina
    Guzman-Taveras, Rosirys
    Jose Mejuto-Marti, Mara
    Fernandez-Villar, Alberto
    Miguel Barros-Dios, Juan
    EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (03) : 947 - 953
  • [34] MOLECULAR PATHOGENESIS OF LUNG CANCER IN NEVER-SMOKERS
    Massion, Pierre P.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S46 - S47
  • [35] LUNG CANCER IN NEVER-SMOKERS: PROGNOSTIC IMPLICATIONS
    Yang, Ping
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S50 - S52
  • [36] Mutation patterns in lung cancer never-smokers
    Gruber, Karl
    LANCET ONCOLOGY, 2015, 16 (04): : E163 - E163
  • [37] Lung cancer in never-smokers: a hidden disease
    Bhopal, Anand
    Peake, Michael D.
    Gilligan, David
    Cosford, Paul
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2019, 112 (07) : 269 - 271
  • [38] Developments in lung cancer biology in never-smokers
    Burki, Talha Khan
    LANCET ONCOLOGY, 2021, 22 (10): : 1363 - 1363
  • [39] Genomic Profiling of Lung Adenocarcinoma in Never-Smokers
    Devarakonda, Siddhartha
    Li, Yize
    Rodrigues, Fernanda Martins
    Sankararaman, Sumithra
    Kadara, Humam
    Goparaju, Chandra
    Lanc, Irena
    Pepin, Kymberlie
    Waqar, Saiama N.
    Morgensztern, Daniel
    Ward, Jeffrey
    Masood, Ashiq
    Fulton, Robert
    Fulton, Lucinda
    Gillette, Michael A.
    Satpathy, Shankha
    Carr, Steven A.
    Wistuba, Ignacio
    Pass, Harvey
    Wilson, Richard K.
    Ding, Li
    Govindan, Ramaswamy
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (33) : 3747 - +
  • [40] The Obesity Paradox in COPD Is Absent in US Never-Smokers
    Wu, T. D.
    McCormack, M. C.
    Wise, R. A.
    Brigham, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199